Expanding the use of SGLT-2 inhibitor to improve cardiorenal disease
Expanding the use of SGLT-2 inhibitor to improve cardiorenal disease
扩大SGLT-2抑制剂的使用以改善心肾疾病
批准号：
491280
负责人：
Odutayo Ayodele
金额：
$7.19万
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-05-01 至 2025-05-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The co-existence of cardiovascular and kidney disease has therefore been acknowledged as a unique clinical entity known as the "cardiorenal syndrome", which is associated with a particularly high risk of heart disease, end-stage heart dysfunction known as
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
